Trials / Unknown
UnknownNCT05461404
Emollient Therapy for Premature Infants in Zimbabwe
Emollient Therapy for Improved Survival and Growth of Very Low Birth Weight Infants in Zimbabwe
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 520 (estimated)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 28 Days
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the efficacy of topical emollient treatments in improving neonatal growth and mortality rates.
Detailed description
For infants whose parent/caretaker provides written informed consent, the study nurse coordinator on-site will allocate infants to one of two strata (700- \<1000 g or 1000-1500 g). Participants within each stratum will be randomly assigned in a 1:1 ratio to one of two treatment groups: 1) high-linoleate SSO, or 2) standard-of-care treatment without use of topical emollients or massage.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Topical Emollient Therapy | Application of high-linoleate (\>60% linoleic acid) SSO to the epidermis. |
Timeline
- Start date
- 2023-08-01
- Primary completion
- 2025-05-31
- Completion
- 2025-12-31
- First posted
- 2022-07-18
- Last updated
- 2023-04-19
Locations
1 site across 1 country: Zimbabwe
Source: ClinicalTrials.gov record NCT05461404. Inclusion in this directory is not an endorsement.